Back to Search
NICOLE WEINREB, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1962447136IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
227616(MA)
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
227616(MA)
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
048587(CT)
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 2003
Research & Publications (20)
Gaucher disease: resetting the clinical and scientific agenda.
PMID 19296473·Am J Hematol·2009
8-other
A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1.
PMID 19195916·Mol Genet Metab·2009
4-observational
A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase.
PMID 18819093·Am J Hematol·2008
8-other
Imiglucerase and its use for the treatment of Gaucher's disease.
PMID 18627336·Expert Opin Pharmacother·2008
6-review
Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.
PMID 18509745·J Inherit Metab Dis·2008
6-review
Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.
PMID 18312448·Clin Genet·2008
8-other
Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.
PMID 18979180·J Inherit Metab Dis·2008
8-other
Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease.
PMID 17539908·Clin Genet·2007
3-trial
The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
PMID 17309642·Clin Genet·2007
8-other
Beneficial response to rituximab in refractory Felty Syndrome.
PMID 16484886·J Clin Rheumatol·2006
8-other
Individualization of long-term enzyme replacement therapy for Gaucher disease.
PMID 15714077·Genet Med·2005
6-review
Guidance on the use of miglustat for treating patients with type 1 Gaucher disease.
PMID 16247743·Am J Hematol·2005
4-observational
Gaucher disease and cancer incidence: a study from the Gaucher Registry.
PMID 15718419·Blood·2005
8-other
Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.
PMID 14722528·J Pediatr·2004
6-review
Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients.
PMID 15468046·Semin Hematol·2004
6-review
Introduction. Advances in Gaucher Disease: therapeutic goals and evaluation and monitoring guidelines.
PMID 15468044·Semin Hematol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 80 S MAIN ST
MIDDLETOWN, CT 06457 - Phone
- (860) 358-6412
Quick Facts
- NPI
- 1962447136
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile